New registry to monitor ion beam therapy results
NCT ID NCT03049072
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry study is collecting data from 2,800 cancer patients treated with ion beam therapy (protons and carbon ions) at MedAustron. Researchers will track tumor response, survival, side effects, and quality of life over time. The goal is to better understand the real-world benefits and risks of this advanced radiation therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Protons and Carbon Ions (radiation therapy)
- What this could lead to
- If successful, this registry could provide valuable data on the effectiveness and side effects of ion beam therapy, helping to refine treatment for future cancer patients.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and other factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ION BEAM RADIATION THERAPY FOR TUMOR PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
EBG MedAustron GmbH
RECRUITINGWiener Neustadt, Lower Austria, 2700, Austria